Compare Stanley Black & Decker, Inc. (SWK) vs 10X Genomics Inc (TXG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Stanley Black & Decker, Inc. vs 10X Genomics Inc — how do they compare? Stanley Black & Decker, Inc. trades at $88.36 (market cap $13.47B), while 10X Genomics Inc trades at $81.9 (market cap $10.07B). The key difference: Stanley Black & Decker, Inc. is the larger of the two by market cap, and Stanley Black & Decker, Inc. pays a 3.77% dividend while 10X Genomics Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Stanley Black & Decker, Inc. for 62 Days and 10X Genomics Inc for 92 Days on average.
| SWK | TXG | |
|---|---|---|
Market Cap | $13.47B | $10.07B |
Volume | 2,859,744 | 5,657,286 |
Sector | Industrials | Health |
52-Week High | $104.00 | $97.74 |
52-Week Low | $62.12 | $11.48 |
Typical Hold Time | 62 Days | 92 Days |
Enterprise Value | $17.63B | $9.59B |
Dividend Yield | 3.77% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Stanley Black & Decker (SWK) trades at $88.31, down 1.87% on the day, with a bearish technical signal from moving averages and oscillators. The company has beaten earnings estimates for the last three quarters, with Q3 2026 results expected November 4, 2026. Fundamentals show modest revenue of $15.13B in 2025 and a net income margin of 4.07%, while valuation ratios like a P/E of 21.8 and P/S of 0.89 suggest reasonable pricing. Recent news highlights product launches like the dustbuster® mini™ and management's focus on margin gains.
The outlook is mixed: analyst consensus is a 'Hold' with a $93 price target, implying ~5% upside, but technical weakness and competitive pressures pose risks. Investment appeal lies in its dividend king status and cost-saving initiatives, though investors face headwinds from higher expenses and market volatility. Earnings growth remains the key catalyst for further upside.
TXG trades at $76.10, down 5.65% on the day, reflecting a bearish technical trend. The company reported revenue of $642.82M for 2025 with a net loss of $43.54M, though it has consistently beaten quarterly EPS estimates. Recent news highlights strong demand for its Atera spatial biology platform and a patent victory. The stock faces resistance near $77 and support at $72.
The outlook is mixed; strong product demand and improving margins offer upside, but persistent losses and high valuation ratios pose risks. Analyst consensus is divided, with a $74.30 price target slightly below the current price, indicating cautious optimism amid execution challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Stanley Black & Decker, Inc.
Stanley Black & Decker Inc is a manufacturer of hand and power tools. The company operates three business segments: tools and storage, security, and industrial. Tools and storage, the largest segment by revenue, sells hand tools and power tools to professional end-users, distributors, retail consumers, and industrial customers. Security installs electronic security systems and provides electronic security services including alarm monitoring and video surveillance. Industrial sells engineered fastening products such as stud-welding systems, blind inserts and tools, and engineered plastic and mechanical fasteners. The largest end market is the United States of America.
Read more on SWK →About 10X Genomics Inc
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →
